pre-IPO PHARMA

COMPANY OVERVIEW

Regenacy Pharmaceuticals is a pioneer in developing novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme ("HDAC") inhibitors.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Neurological DIsorders
  • Oncology
  • Rare Diseases

  • WEBSITE

    https://regenacy.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    For More Press Releases


    Google Analytics Alternative